Primaquine Administration after Falciparum Malaria Treatment in Malaria Hypoendemic Areas with High Incidence of Falciparum and Vivax Mixed Infection: Pros and Cons
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mixed infections of Plasmodium falciparum and Plasmodium vivax is high (~ 30%) in some malaria hypoendemic areas where the patients present with P. falciparum malaria diagnosed by microscopy. Conventional treatment of P. falciparum with concurrent chloroquine and 14 days of primaquine for all falciparum malaria patients may be useful in areas where mixed falciparum and vivax infections are high and common and also with mild or moderate G6PD deficiency in the population even with or without subpatent vivax mixed infection. It will be possibly cost-effective to reduce subsequent vivax illness if the patients have mixed vivax infection. Further study to prove this hypothesis may be warranted.
Abstract
Mixed infections of Plasmodium falciparum and Plasmodium vivax is high (~ 30%) in some malaria hypoendemic areas where the patients present with P. falciparum malaria diagnosed by microscopy. Conventional treatment of P. falciparum with concurrent chloroquine and 14 days of primaquine for all falciparum malaria patients may be useful in areas where mixed falciparum and vivax infections are high and common and also with mild or moderate G6PD deficiency in the population even with or without subpatent vivax mixed infection. It will be possibly cost-effective to reduce subsequent vivax illness if the patients have mixed vivax infection. Further study to prove this hypothesis may be warranted.
참고문헌 (14)
- Luxemburger C, "The epidemiology of severe malaria in an area of low transmission in Thailand", Trans R Soc Trop Med Hyg, 91, pp.256~262 (1997)
- Ministry of Public Health, "Thailand", ~ (2009), unpublished data
- Looareesuwan S, "High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand", Lancet, 2, pp.1052~1055 (1987)
- Krudsood S, "Hidden Plasmodium falciparum infections", Southeast Asian J Trop Med Public Health, 30, pp.623~624 (1999)
- Wilairatana P, "Efficacy of primaquine-resistant Plamodium vivax in Thailand", Am J Trop Med Hyg, 61, pp.973~977 (1999)
- Mason DP, "Can treatment of P. vivax lead to an unexpected appearance of falciparum malaria?", Southeast Asian J Trop Med Public Health, 32, pp.57~63 (2001)
- Mayxay M, "Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria", Am J Trop Med Hyg, 65, pp.588~592 (2001)
- Maitland K, "The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo Island, Vanuatu", Trans R Soc Trop Med Hyg, 90, pp.614~620 (1996)
- Takagi T, "Submicroscopic double infection of Plasmodium falciparum in P. vivax malaria", Trans R Soc Trop Med Hyg, 82, pp.384~ (1988)
- Siribal S, "Identification of human malaria parasites and detection of mixed infection in Thai patients by nested PCR", Southeast Asian J Trop Med Public Health, 35, pp.5~9 (2004)
- Katakai Y, "Application of real-time polymerase chain reaction (PCR) analysis for detection and discrimination of malaria parasite species in Thai patients", Southeast Asian J Trop Med Public Health, 35, pp.10~14 (2004)
- Baird JK, "Prevention and treatment of vivax malaria", Curr Inf Dis Rep, 9, pp.39~46 (2007)
- White NJ, "Malaria. In Manson’s Tropical Diseases. 22nd ed", pp.1274~ (2009), Saunders
- Bryan JP, "Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis", Am J Trop Med Hyg, 75, pp.416~420 (2006)